The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. BPC 157 TB 500 Capsules Starts at $249 BPC 157: Miracle Healing Peptide or Hidden Danger?